LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 51 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,510,000 | +4.6% | 10,000,000 | 0.0% | 0.06% | -6.8% |
| Q3 2020 | $9,091,000 | +4.1% | 10,000,000 | 0.0% | 0.06% | -4.8% |
| Q2 2020 | $8,730,000 | -29.7% | 10,000,000 | -33.3% | 0.06% | -36.1% |
| Q1 2020 | $12,422,000 | -4.7% | 15,000,000 | 0.0% | 0.10% | +51.6% |
| Q4 2019 | $13,033,000 | +4.1% | 15,000,000 | 0.0% | 0.06% | -5.9% |
| Q3 2019 | $12,515,000 | -3.3% | 15,000,000 | 0.0% | 0.07% | -5.6% |
| Q2 2019 | $12,940,000 | – | 15,000,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penn Mutual Asset Management | 1,214,000 | $1,164,000 | 1.57% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,027,000 | 1.44% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,336,000 | 0.26% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,472,000 | $19,704,000 | 0.23% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,952,000 | $5,782,000 | 0.16% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,916,000 | 0.12% |
| Cutler Capital Management, LLC | 300,000 | $287,000 | 0.11% |
| Radcliffe Capital Management, L.P. | 3,117,000 | $2,985,000 | 0.07% |
| PROSPECTOR PARTNERS LLC | 400,000 | $383,000 | 0.06% |
| Financial Sense Advisors, Inc. | 130,000 | $125,000 | 0.05% |